证券代码：688625 证券简称：呈和科技 公告编号： 2023-062 呈和科技股份有限公司 关于召开 2023 年半年度业绩暨现金分红说明会的公告 三、 参加人员 会议召开时间：2023 年 08 月 30 日(星期三) 下午 16:00-17:00 会议召开地点：上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 （二） 会议召开地点：上证路演中心 （三） 会议召开方式：上证路演中心网络互动 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 投资者可于 2023 年 08 月 23 日(星期三) 至 08 月 29 日(星期二)16:00 前登录上证路演 中心网站首页点击"提问预征集"栏目或通过公司邮箱（ir@gchchem.com）进行提问。公司 将在说明会上对投资者普遍关注的问题进行回答。 呈和科技股份有限公司（以下简称"公司"）已于 2023 年 08 月 18 日发布公司《2023 年 年半年度报告》及《关于公司 2 ...

Financial Performance - The company's operating revenue for the first half of 2023 reached ¥369,632,844.55, representing an increase of 11.86% compared to ¥330,438,210.99 in the same period last year [23]. - The net profit attributable to shareholders for the first half of 2023 was ¥108,779,304.66, up 10.59% from ¥98,360,059.35 in the previous year [23]. - The net profit after deducting non-recurring gains and losses increased by 20.08%, amounting to ¥103,244,062.49 compared to ¥85,977,612.96 in the same period last year [23]. - The company's net cash flow from operating activities decreased by 19.52%, totaling ¥85,164,493.59, down from ¥105,819,430.78 in the previous year [23]. - The total assets at the end of the reporting period were ¥2,746,914,816.87, reflecting a 14.94% increase from ¥2,389,783,591.35 at the end of the previous year [23]. - The net assets attributable to shareholders increased by 19.53%, reaching ¥1,263,449,423.61 compared to ¥1,057,028,197.81 at the end of the previous year [23]. - Basic earnings per share for the first half of 2023 were ¥0.81, a 9.46% increase from ¥0.74 in the same period last year [24]. - The company's revenue for the first half of 2023 reached RMB 369.63 million, representing a year-on-year growth of 11.86% [60]. - The net profit attributable to shareholders for the same period was RMB 108.78 million, an increase of 10.59% year-on-year [60]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 103.24 million, reflecting a year-on-year growth of 20.08% [60]. Research and Development - The company increased its R&D investment to ¥15,834,083.43, a 13.13% increase compared to ¥13,996,723.05 in the same period last year [46]. - R&D investment accounted for 4.28% of total revenue, up by 0.04 percentage points from 4.24% in the previous year [46]. - The company holds a total of 56 valid patents, including 49 invention patents and 7 utility model patents, with 5 new invention patent applications filed during the reporting period [45]. - The company has developed several advanced technologies, including a β crystal toughening nucleating agent, which is a first in the industry [43]. - The company has established a long-term technical exchange and cooperation with customers to ensure R&D innovation meets market demand [43]. - The company has introduced advanced experimental analysis and testing instruments to enhance its R&D capabilities [43]. - The company has completed projects on calcium salt toughening nucleating agents and high-gloss low-warp nucleating agents, with total investments of RMB 400 million and RMB 250 million respectively [49]. - The company has developed a new type of sorbitol-based nucleating agent with an investment of RMB 450 million, achieving small-scale trial success and preparing for pilot production [50]. - The company has successfully integrated the R&D and production of special antioxidants through acquisitions, enhancing its product line and market reach [53]. Market and Industry Trends - The high-performance resin and modified plastics industry is experiencing significant growth, with production capacity doubling due to increased demand from downstream sectors like automotive and home appliances [37]. - The domestic market for high-end modified plastics remains reliant on imports, indicating a strong potential for domestic production to meet growing demand [38]. - The nucleating agent market in China has seen an increase in import substitution rate from 19% in 2017 to 28% in 2022, with expectations to reach 34% by 2025 [40]. - The synthetic hydrotalcite market is positioned for growth as it serves as a non-toxic, efficient heat stabilizer for PVC, with increasing regulatory support for green materials [41]. - The antioxidant market is entering a phase of intense competition, driven by rising demand in emerging industries such as new energy vehicles and healthcare services [42]. - The market for modified plastics is expanding into high-tech fields, indicating a broadening application scope and increasing demand for differentiated high-end products [38]. Corporate Governance and Compliance - The report highlights that the company has not faced any non-operating fund occupation by controlling shareholders or related parties [7]. - The board of directors has confirmed the authenticity, accuracy, and completeness of the financial report for the first half of 2023 [4]. - The report indicates that the financial report has not been audited [5]. - The company emphasizes that forward-looking statements do not constitute a commitment to investors [6]. - There are no special arrangements for corporate governance mentioned in the report [6]. - The company has confirmed that there are no violations in decision-making procedures regarding external guarantees [8]. - The report does not indicate any inability of the majority of directors to ensure the report's authenticity and completeness [9]. - The company has not faced any administrative penalties related to environmental issues during the reporting period [111]. - The company has committed to protecting investors' rights and will take necessary measures if it fails to meet its obligations [131]. Environmental Responsibility - The company is committed to green and sustainable development, focusing on low-carbon transformation and the production of environmentally friendly materials [60]. - The company allocated RMB 429.77 million for environmental protection during the reporting period [97]. - The company’s environmental facilities operated effectively, with no penalties from environmental authorities during the reporting period [98]. - The company achieved a pH value of 7.3-7.4 for wastewater discharge, meeting the standard limit of 6.5-9 [99]. - Chemical oxygen demand (COD) in wastewater was recorded at 47 mg/L, below the standard limit of 50 mg/L [99]. - The company has implemented effective pollution control measures, with all monitored pollutants meeting regulatory standards [106]. - The company actively participated in the "Waste-Free Factory" initiative, integrating green low-carbon concepts into the entire industrial production process [112]. - The company adopted clean energy measures, including natural gas and solar street lights, to reduce carbon emissions and promote a low-carbon lifestyle among employees [112]. Shareholder and Stock Management - The company plans to distribute a cash dividend of RMB 6.00 per 10 shares, totaling RMB 81,196,618.80 based on a total share capital of 135,327,698 shares [5]. - The profit distribution proposal is pending approval from the shareholders' meeting [5]. - The company has committed to a continuous and stable profit distribution policy, prioritizing cash dividends, with a minimum of 80% cash dividend allocation for mature companies without major capital expenditure plans [135]. - The company has committed to reducing solid waste through the principles of reduction, resource utilization, and harmless treatment [112]. - The company plans to repurchase shares to stabilize stock prices, ensuring the repurchase price does not exceed the latest audited net asset value per share [120]. - The controlling shareholder's funds for share purchases must be no less than 30% and no more than 50% of their after-tax salary from the previous year [122]. - The company must announce the share repurchase decision within 15 trading days after the triggering conditions are met [124]. - The share repurchase plan must be completed within 30 trading days after the shareholders' meeting resolution [124]. Investment and Acquisitions - The company completed the acquisition of Tangshan Keao Chemical and Tianjin Xindafeng, with a total investment of RMB 10,800 million, of which RMB 8,100 million has been paid as of the reporting period [81]. - The acquisition of 100% equity in Kao Chemical is part of the company's strategy for market expansion, with a committed investment of ¥75,200,000 [153]. - The company has raised and utilized up to RMB 400 million of idle self-owned funds for cash management, with a balance of RMB 78 million as of June 30, 2023 [160]. - The company has utilized ¥158,240,220.22 of idle raised funds for temporary working capital, with a repayment of ¥193,700,220.22 made by April 2023 [157]. Risks and Challenges - The company faces risks related to raw material price increases and supply chain disruptions, which could adversely affect operational performance [68]. - The accounts receivable balance at the end of the reporting period was RMB 193.88 million, representing 52.45% of the current operating income, indicating potential risks related to bad debts [65]. - The company’s overseas revenue amounted to RMB 61.04 million, accounting for 16.51% of total revenue, exposing it to foreign exchange risks [66].

证券代码：688625 证券简称：呈和科技 公告编号：2023-058 呈和科技股份有限公司 第三届监事会第十次会议决议公告 本公司监事会及全体监事成员保证公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 （一）呈和科技股份有限公司（以下简称"公司"）第三届监事会第十次会议的通知及会 议资料已于 2023 年 8 月 5 日以电子邮件、专人发放及电话通知等方式向全体监事、高级管理 人员送达，监事会会议通知包括会议的相关材料，同时列明了会议的召开时间、地点、内容 和方式。 （二）本次会议于 2023 年 8 月 16 日下午在公司会议室召开，采取现场投票的方式进行 表决。本次会议应出席监事三人，实际出席监事三人。会议由监事会主席何洁冰女士主持， 公司全体高级管理人员列席了本次会议。 （三）本次会议的召集和召开程序符合《中华人民共和国公司法》《上海证券交易所科创 板股票上市规则》等相关法律、行政法规、部门规章、规范性文件及《呈和科技股份有限公 司章程》（以下简称"《公司章程》"）的规定，会议决议合法、有效。 具体内容详见公司同日在上 ...

科创板上市公司独立董事候选人声明与承诺 本人阙占文,已充分了解并同意由提名人呈和科技股份有限公司 董事会提名为呈和科技股份有限公司第三届董事会独立董事候选人。 本人公开声明,本人具备独立董事任职资格,保证不存在任何影响本 人担任皇和科技股份有限公司独立董事独立性的关系,具体声明并承 诺如下: 一、本人具备上市公司运作的基本知识,熟悉相关法律、行政法 规、部门规章及其他规范性文件,具有五年以上法律、经济会计、财 务、管理等履行独立董事职责所必需的工作经验。 二、本人任职资格符合下列法律、行政法规和部门规章以及公司 规章的要求: (一)《中华人民共和国公司法》等关于董事任职资格的规定; (二)《中华人民共和国公务员法》关于公务员兼任职务的规定 (如适用): (三)中国证监会《上市公司独立董事管理办法》和上海证券交 易所自律监管规则有关独立董事任职资格和条件的相关规定; (四)中共中央纪委、中共中央组织部《关于规范中管干部辞去 公职或者退(离)休后担任上市公司、基金管理公司独立董事、独立 监事的通知》的规定(如适用); (五)中共中央组织部《关于进一步规范党政领导干部在企业兼 职 (任职) 问题的意见》的相关规定 ...

二、本人任职资格符合下列法律、行政法规和部门规章以及公司 规章的要求: (一)《中华人民共和国公司法》等关于董事任职资格的规定; (二)《中华人民共和国公务员法》关于公务员兼任职务的规定 (如适用): 科创板上市公司独立董事候选人声明与承诺 一、本人具备上市公司运作的基本知识,熟悉相关法律、行政法 规、部门规章及其他规范性文件,具有五年以上法律、经济会计、财 务、管理等履行独立董事职责所必需的工作经验。 (三)中国证监会《上市公司独立董事管理办法》和上海证券交 易所自律监管规则有关独立董事任职资格和条件的相关规定; 本人燕学善,已充分了解并同意由提名人呈和科技股份有限公司 董事会提名为呈和科技股份有限公司第三届董事会独立董事候选人。 本人公开声明,本人具备独立董事任职资格,保证不存在任何影响本 人担任呈和科技股份有限公司独立董事独立性的关系,具体声明并承 诺如下: (四)中共中央纪委、中共中央组织部《关于规范中管干部辞去 公职或者退（离）休后担任上市公司、基金管理公司独立董事、独立 监事的通知》的规定(如适用); (五)中共中央组织部《关于进一步规范党政领导干部在企业兼 职（任职）问题的意见》的相关规定(如适 ...

二、关于公司 2023 年半年度利润分配预案的议案 呈和科技股份有限公司独立董事 关于公司第二届董事会第二十三次会议相关事项的独立意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《呈和科技股份有限公司 章程》（以下简称"《公司章程》"）、《呈和科技股份有限公司独立董事工作细则》的有关 规定，我们作为呈和科技股份有限公司（以下简称"公司"）的独立董事，本着认真、负责的 态度，基于独立、审慎、客观的原则，认真审阅了本次会议的相关资料，对公司第二届董事 会第二十三次会议审议相关事项发表独立意见如下： 一、关于公司《2023 年半年度募集资金存放与使用情况专项报告》的议案 我们认为，公司 2023 年半年度募集资金存放与使用情况符合《上海证券交易所科创板股 票上市规则》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等 法律法规、规范性文件的相关规定，符合公司《募集资金管理制度》的规定，对募集资金进 行了专户存储和专项使用，并及时履行了相关信息披露义务，募集资金具体使用情况与公司 已披露情况一致，不存在变相改变募集资金用途和损害股东利益的情况，不存在违规使用募 集资金的情况。 我们 ...

科创板上市公司独立董事提名人声明与承诺 提名人呈和科技股份有限公司董事会,现提名阙占文为旱和科技 股份有限公司第三届董事会独立董事候选人,并已充分了解被提名人 职业、学历、职称、详细的工作经历、全部兼职、有无重大失信等不 良记录等情况。被提名人已书面同意出任呈和科技股份有限公司第三 届董事会独立董事候选人(参见该独立董事候选人声明)。提名人认 为,被提名人具备独立董事任职资格,与呈和科技股份有限公司之间 不存在任何影响其独立性的关系,具体声明并承诺如下: 一、被提名人具备上市公司运作的基本知识,熟悉相关法律、行 政法规、规章及其他规范性文件,具有五年以上法律、经济、会计、 财务、管理等履行独立董事职责所必需的工作经验。 被提名人已经参加培训并取得证券交易所认可的相关培训证明 材料(如有)。 二、被提名人任职资格符合下列法律、行政法规和部门规章的要 求: (一)《中华人民共和国公司法》等关于董事任职资格的规定: (二)《中华人民共和国公务员法》关于公务员兼任职务的规定 (如适用); (三)中国证监会《上市公司独立董事管理办法》、上海证券交 易所自律监管规则以及公司章程有关独立董事任职资格和条件的相 关规定: ( ...

中信证券股份有限公司 关于呈和科技股份有限公司 部分募投项目延期的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐机构"）作为呈和科技股份有限公 司（以下简称"呈和科技"或"公司"）持续督导保荐机构履行持续督导职责，根据《证券发 行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年修订）》《上海证券交易所科创板上 市公司自律监管指引第 1 号——规范运作》以及《上海证券交易所上市公司自律监管指南第 1 号——公告格式》等法律法规的相关规定，就呈和科技关于募投项目延期的事项进行了审 慎核查，核查的具体情况如下： 截止 2023 年 6 月 30 日，公司上述募投项目募集资金的具体使用情况如下： 单位：人民币万元 | 序 | 项目名称 | 募 集 | 后 资 | 投 | 截止 2023 6 | 年 | 月 | 30 | 日累计 | 截至 2023 | 年 6 | 月 30 | 日 | 投入比例 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | -- ...

证券代码：688625 证券简称：呈和科技 公告编号：2023-054 呈和科技股份有限公司 呈和科技股份有限公司（ 以下简称（ 公司"）于 2023 年 8 月 16 日召开了第二届董事会第 二十三次会议及第三届监事会第十次会议，审议通过了《关于使用募集资金置换预先投入募 投项目及支付发行费用的自筹资金的议案》，现将相关情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会的《关于同意呈和科技股份有限公司向特定对象发行股票注 册的批复》 证监许可[2023]878 号）核准，并经上海证券交易所同意，公司向特定对象发行 股票 1,994,298 股，每股面值为人民币 1.00 元，募集资金总额为人民币 97,959,917.76 元，扣 除已支付的保荐承销费用 含增值税）人民币 2,900,000.00 元后，实际到账金额为人民币 95,059,917.76 元。上述资金于 2023 年 6 月 19 日到达公司募集资金专户，经立信会计师事务 所 特殊普通合伙）予以验资并出具《验资报告》 信会师报字[2023]第 ZC10356 号）。本次 发行过程中，公司支付发行费用（ 不含增值税）人民币 5,92 ...